beststemcellinbangkok
Autologous

Adipose-Derived Cells / SVF

Autologous cell-based preparations obtained from the patient's fat tissue.

Request a Suitability Review

Overview

Adipose-derived cell preparations are obtained from the patient's own fat tissue through a medically supervised collection procedure.

After collection, the tissue may be processed to isolate a cell-rich fraction. Stromal vascular fraction, commonly called SVF, may contain a mixture of stromal cells, vascular-associated cells, immune cells and other supporting components.

Important distinction

SVF is not the same as a purified or laboratory-expanded MSC product. The composition can vary depending on the collection and processing method.

Typical process

  1. 1Medical assessment
  2. 2Selection of the fat-collection area
  3. 3Local anaesthesia or sedation
  4. 4Collection of adipose tissue
  5. 5Processing according to the permitted protocol
  6. 6Product assessment
  7. 7Administration and follow-up

Questions to ask your provider

  • Is the product minimally processed tissue, SVF or cultured cells?
  • What method is used to process the tissue?
  • What cells are expected in the preparation?
  • Is viability measured?
  • Is sterility testing available?
  • Is the procedure permitted under applicable regulations?
  • What are the risks of collection and administration?

Possible risks

Please review carefully
  • Pain, swelling or bruising
  • Bleeding
  • Infection
  • Irregularity at the collection site
  • Anaesthesia-related risks
  • Contamination if processing is not properly controlled

Limitations

Adipose-derived preparations should not be described as guaranteed treatments. Product composition, evidence and regulatory status can differ significantly.

Practical points before you book

  1. Step 1
    Confirm the doctor performing the harvest is licensed
  2. Step 2
    Ask about regulatory framework and consent
  3. Step 3
    Confirm realistic expectations

Medical suitability notice

This content is provided for general education and does not constitute medical advice. Cell-based therapies differ in source, processing, regulatory status and supporting evidence. Suitability must be determined by a qualified medical professional after individual assessment. Results cannot be guaranteed.

Not sure if this fits your case?

Send your medical documents to our Bangkok coordination team for a doctor-led review.

Request a Suitability Review

Related educational pages

Continue with closely related topics from this guide.

Autologous
Autologous Stem Cells
Autologous stem cells are collected from the patient's own body, commonly from bone marrow, adipose tissue or peripheral blood. Because the cells come from the same person, donor compatibility is not required. Collection procedures, processing time and suitability vary depending on the selected cell source.
Allogeneic
Allogeneic Stem Cells
Allogeneic stem cells are obtained from a screened donor rather than from the patient. Potential sources may include umbilical cord tissue, Wharton's Jelly, placenta, amniotic tissue or cord blood. Donor screening, laboratory processing and product quality documentation should be reviewed before treatment.
Allogeneic
Umbilical Cord MSCs
Umbilical cord MSCs are donor-derived mesenchymal stromal cells obtained from donated birth tissue after delivery. They are commonly discussed in regenerative medicine because they can be collected without an invasive procedure for the recipient. Patients should ask about the exact tissue source, donor screening, cell passage and laboratory testing.
← Back to all stem cell types